Literature DB >> 9636361

Mouse adenovirus type-1 replication is restricted to vascular endothelium in the CNS of susceptible strains of mice.

P C Charles1, J D Guida, C F Brosnan, M S Horwitz.   

Abstract

Previous studies have shown that mouse adenovirus type-1 (MAV-1) caused a fatal hemorrhagic encephalitis in certain strains of mice. C57BI/6 mice exhibited 100% mortality when given as little 10(3) plaque-forming units (PFU) of MAV, in contrast to BALB/c mice which were resistant to as many as 10(6) PFU. Susceptible animals died with a flaccid paralysis on the 3rd or 4th day after inoculation. The brains and spinal cords of these animals displayed numerous petechial hemorrhages that were found in virtually all areas of the brain, but were more numerous in white matter. In this paper, immunohistochemistry and electron microscopy were used to identify the viral target of replication within the CNS of susceptible mice. These studies showed that the CNS vascular endothelial cell was the primary site of viral replication within the CNS of mice infected with MAV-1. Characterization of cytokine mRNA levels and disease course in immunodeficient mice revealed that the host immune response played little, if any, role in the pathogenesis of MAV-1 disease in susceptible mice and was not responsible for the resistance of BALB/c mice. These results support the conclusion that disease course and outcome in susceptible and resistant strains of mice were determined primarily by the ability of the virus to replicate within the CNS vascular endothelium.

Entities:  

Mesh:

Year:  1998        PMID: 9636361     DOI: 10.1006/viro.1998.9180

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  27 in total

Review 1.  Microbes' roadmap to neurons.

Authors:  Krister Kristensson
Journal:  Nat Rev Neurosci       Date:  2011-05-18       Impact factor: 34.870

2.  SJL/J mice are highly susceptible to infection by mouse adenovirus type 1.

Authors:  K R Spindler; L Fang; M L Moore; G N Hirsch; C C Brown; A Kajon
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

Review 3.  Murine adenoviruses: tools for studying adenovirus pathogenesis in a natural host.

Authors:  Silvio Hemmi; Katherine R Spindler
Journal:  FEBS Lett       Date:  2019-12-06       Impact factor: 4.124

4.  Mouse adenovirus type 1 infection in SCID mice: an experimental model for antiviral therapy of systemic adenovirus infections.

Authors:  L Lenaerts; E Verbeken; E De Clercq; L Naesens
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

5.  E1A-CR3 interaction-dependent and -independent functions of mSur2 in viral replication of early region 1A mutants of mouse adenovirus type 1.

Authors:  Lei Fang; Katherine R Spindler
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

6.  Usage of integrin and heparan sulfate as receptors for mouse adenovirus type 1.

Authors:  Sharmila Raman; Tien-Huei Hsu; Shanna L Ashley; Katherine R Spindler
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

7.  Mouse adenovirus type 1 infection of natural killer cell-deficient mice.

Authors:  Amanda R Welton; Lisa E Gralinski; Katherine R Spindler
Journal:  Virology       Date:  2007-12-21       Impact factor: 3.616

8.  Fatal disseminated mouse adenovirus type 1 infection in mice lacking B cells or Bruton's tyrosine kinase.

Authors:  Martin L Moore; Erin L McKissic; Corrie C Brown; John E Wilkinson; Katherine R Spindler
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

9.  Mouse adenovirus type 1-induced breakdown of the blood-brain barrier.

Authors:  Lisa E Gralinski; Shanna L Ashley; Shandee D Dixon; Katherine R Spindler
Journal:  J Virol       Date:  2009-07-01       Impact factor: 5.103

10.  T cells cause acute immunopathology and are required for long-term survival in mouse adenovirus type 1-induced encephalomyelitis.

Authors:  Martin L Moore; Corrie C Brown; Katherine R Spindler
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.